Subscribe to RSS
DOI: 10.1160/TH13-01-0017
CCR6 selectively promotes monocyte mediated inflammation and atherogenesis in mice
Financial support: This work was supported by the Deutsche Forschungsgemeinschaft (Hu1618/1–2 to R.R.K, and SFB688 TP A12, ZE 827/1–2 and ZE 827/4–1 to A.Z.), and ZonMW VIDI 016.126.358 to R.R.K.Publication History
Received:
09 January 2013
Accepted after major revision:
19 August 2013
Publication Date:
30 November 2017 (online)


Summary
The chemokine receptor CCR6 is expressed by various cell subsets implicated in atherogenesis, such as monocytes, Th17 and regulatory T cells. In order to further define the role of CCR6 in atherosclerosis, CCR6-deficient (Ccr6 -/-) mice were crossed with low-density lipoprotein receptor-deficient (Ldlr -/-) mice to generate atherosclerosis-prone mice deficient in CCR6. Compared to Ldlr -/- controls, atherosclerotic burden in the aortic sinus and aorta were reduced in Ccr6 -/- Ldlr -/- mice fed a high fat diet, associated with a profound depression in lesional macrophage accumulation. Local and systemic distributions of T cells, including frequencies of Th1, Th17 and regulatory T cells were unaltered. In contrast, circulating counts of both Gr-1high and Gr1low monocytes were reduced in Ccr6 -/- Ldlr -/- mice. Moreover, CCR6 was revealed to promote monocyte adhesion to inflamed endothelium in vitro and leukocyte adhesion to carotid arteries in vivo. Finally, CCR6 selectively recruited monocytes but not T cells in an acute inflammatory air pouch model. We here show that CCR6 functions on multiple levels and regulates the mobilisation, adhesion and recruitment of monocytes/macrophages to the inflamed vessel, thereby promoting atherosclerosis, but is dispensable for hypercholesterolaemia-associated adaptive immune priming. Targeting CCR6 or its ligand CCL20 may therefore be a promising therapeutic strategy to alleviate atherosclerosis.
Note: The review process for this manuscript was fully handled by G. Y. H. Lip, Editor in Chief.
* Equal contribution by these authors.